In this photo taken Aug. 21, 2012, Dr. Tara Palmore, deputy hospital epidemiologist at the National Institutes of Health Clinical Center, left, and Dr. Julie Segre, a geneticist with the National Human Genome Research Institute, pose at the NIH Clinical Center in Bethesda, Md. Last year a deadly superbug spread through the nation's leading research hospital, killing six patients before it could be stopped. Scientists at the National Institutes of Health hospital in Bethesda, Md., scrubbed with bleach, locked down patients and even ripped out plumbing. In the end, it took gene detectives analyzing the germ's DNA to trace it to its source. It came from a New York City patient who was admitted for a medical study. (AP Photo/Patrick Semansky)
BETHESDA, Md. (AP) — A deadly germ untreatable by most antibiotics has killed a seventh person at the National Institutes of Health Clinical Center in Maryland.
The Washington Post reported the death Friday. NIH officials told the paper that the boy from Minnesota died Sept. 7. NIH says the boy arrived at the research hospital in Bethesda in April and was being treated for complications from a bone marrow transplant when he contracted the bug.
He was the 19th patient at the hospital to contract an antibiotic-resistant strain of KPC, or Klebsiella pneumoniae. The outbreak stemmed from a single patient carrying the superbug who arrived at the hospital last summer.
The paper reported the Minnesota boy's case marked the first new infection of this superbug at NIH since January.
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to email@example.com. Please provide detailed information.